课题基金 / 基金详情

Modulation of Cyclin D1 Expression by Integrin Signals in Oral Squamous Carcinoma Cells

Modulation of Cyclin D1 Expression by Integrin Signals in Oral Squamous Carcinoma Cells
口腔鳞状细胞癌细胞中整合素信号对细胞周期蛋白 D1 表达的调节
批准号:
15592000
负责人:
KAWANO Kenji
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

KAWANO Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cyclin D1 overexpression is frequently detected in oral squamous cell carcinomas (OSCC) and it is closely associated with the survival of OSCC patients. We examined cyclin D1 gene amplification with a panel of OSCC cell lines by the differential PCR technique. Any OSCC cell lines examined, however, did not show gene amplification of cyclin D1. Then, the expression of phosphorylated GSK-3β was examined by Western blotting, and was compared with cyclin D1 expression in OSCC cells. Interestingly, the expression of phosphorylated GSK-3β was reversely correlated with cyclin D1 expression, suggesting that lack of phosphorylated GSK-3β causes the intracellular accumulation of cyclin D1 in OSCC cells.Next, we tested cyclin D1 expression in various culture conditions, such as culturing with 10% FBS-containing medium or serum-free medium, as monolayer culture cells or multicellular aggregates (MCA), and on specific extracellular matrix proteins-coated surfaces or non-coated surface, and we found no differences in cyclin D1 level under these culture conditions. Furthermore, localizations of cyclin D1, GSK-3, Akt and Erk were investigated in monolayer cells and MCAs by immunofluorescent stainings. Results showed diffuse positive reactions without any differences between these proteins and between both the culture conditions.In this project, we could not present definite evidence of involvement of integrin signals in cyclin D1 expression in OSCC cell lines. Further studies are required to clarify the mechanism of modulation of GSK-3β functionality in OSCC.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2006
期刊: Head and Neck 28(In press)
影响因子: --
作者: [Kenji Kawano, Shigetaka Yanagisawa]
通讯作者: Shigetaka Yanagisawa
Roles of N-cadherin in invasion and metastasis of E-cadherin-negative oral squamous carcinoma cell lines
N-cadherin在E-cadherin阴性口腔鳞癌细胞系侵袭和转移中的作用
DOI: --
发表时间: 2005
期刊: Oral Oncology ; Proceedings of 10th ICOOC 10
影响因子: --
作者: [Yamazaki M, Ohshiro K, Cheng J, Ida H, Kawamura H, Saku T, Morisaki I, Kenji Kawano et al.]
通讯作者: Kenji Kawano et al.
Kenji Kawano et al.: "Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma"International Journal of Oral & Maxillofacial Surgery. 32・6. 633-637 (2003)
Kenji Kawano 等人:“免疫组织化学胸苷酸合酶表达对口腔鳞状细胞癌替加氟/尿嘧啶 (UFT) 组织学反应的预测价值”国际口腔颌面外科杂志 32・6 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间: 2006
期刊: International Journal of Oral & Maxillofacial Surgery 35
影响因子: --
作者: [Kenji Kawano et al.]
通讯作者: Kenji Kawano et al.
Research of target molecule of eosinophilic rhinosinusitis by pharmacogenomics of steroids
  • 批准号:
    22791633
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.5万
  • 财政年份:
    2010
  • 负责人:
    KAWANO Kenji
  • 依托单位:
Neural mechanisms for detecting and integrating visual motion
  • 批准号:
    21240037
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 资助金额:
    $29.37万
  • 财政年份:
    2009
  • 负责人:
    KAWANO Kenji
  • 依托单位:
The attitude of the younger age group to suicide
Establishment of invasion/metastasis inhibition therapy against oral squamous cell carcinomas : a basic study.
  • 批准号:
    20592205
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    2008
  • 负责人:
    KAWANO Kenji
  • 依托单位:
国内基金
海外基金
新型铜载体天然产物Chalkphomycin通过ATM酶-CHK2-Cyclin D1轴抗黑色素瘤作用机制研究
  • 批准号:
    2025JJ80302
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    龚邦
  • 依托单位:
tRF-28-ZJ47D112Z4DZ通过Cyclin D1/CDK4抑制胃癌发生的机制及其早期诊断价值研究
  • 批准号:
    82302611
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    俞秀冲
  • 依托单位:
Anxa2调控Cyclin D1促进乳腺癌细胞他莫昔芬耐药及侵袭性增强的机制研究
  • 批准号:
    82272640
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    王彤
  • 依托单位:
LncRNA-CASC2/miR-155-5p/cyclin D1轴在妊娠期亚甲减绒毛外滋养细胞侵袭迁移中的作用及补肾安胎方的干预研究
  • 批准号:
    --
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    33万元
  • 批准年份:
    2022
  • 负责人:
    张泰魏
  • 依托单位: